The role of targeted therapy for gastrointestinal tumors. - Wikidata - wikimedia - TriplyDB

The role of targeted therapy for gastrointestinal tumors.

The role of targeted therapy for gastrointestinal tumors.

http://www.wikidata.org/entity/Q38222585

about

What links BRAF to the heart function? New insights from the cardiotoxicity of BRAF inhibitors in cancer treatment New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: do all roads lead to RAS?The changes of lipid metabolism in advanced renal cell carcinoma patients treated with everolimus: a new pharmacodynamic marker?Fasting potentiates the anticancer activity of tyrosine kinase inhibitors by strengthening MAPK signaling inhibition.Nuclear Drosha enhances cell invasion via an EGFR-ERK1/2-MMP7 signaling pathway induced by dysregulated miRNA-622/197 and their targets LAMC2 and CD82 in gastric cancer Conquests and perspectives of cardio-oncology in the field of tumor angiogenesis-targeting tyrosine kinase inhibitor-based therapy.Hepatocellular carcinoma treatment over sorafenib: epigenetics, microRNAs and microenvironment. Is there a light at the end of the tunnel?Photoactivatable Caged Prodrugs of VEGFR-2 Kinase Inhibitors.Tumor suppressor microRNA-31 inhibits gastric carcinogenesis by targeting Smad4 and SGPP2.[Molecular pathology of colorectal cancer].From standard to new genome-based therapy of gastric cancer.

P2860

Q26782585-D6AA82AA-D158-47DC-A3C1-C3CD6CC1EDFF Q26796348-8A0FD4AE-08C9-4F43-8FDE-E85605F21146 Q35464515-2115F572-EE96-43FD-A627-CD6774DC69EB Q35828447-4FC10D57-B56D-41BD-ABCB-EE4F090D7DFF Q37745502-1E968A04-3ECA-4BB0-A5B9-9EC3F90AC29D Q38286128-DD7FE972-621F-4912-B3D5-1312FFEBF73B Q38554626-F5FB4C48-F58A-4316-9433-F3262999D6E9 Q38773791-99084DE5-73AC-409F-985B-25CD7524FCE6 Q38825712-3C06BFE2-72CC-4D98-968F-78E4FF7C6E3E Q53581884-6D63A112-0908-42A6-B5E7-86257FBEDEBB Q53836060-8C8C5127-4DA6-44E5-BE5B-0A5D9863FC87

P2860

The role of targeted therapy for gastrointestinal tumors.

http://www.wikidata.org/entity/Q38222585

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

The role of targeted therapy for gastrointestinal tumors.

@en

type

label

The role of targeted therapy for gastrointestinal tumors.

@en

prefLabel

The role of targeted therapy for gastrointestinal tumors.

@en

P1433

Q38222585-4A2C9D1A-DF1D-4220-932E-AA5ECDB3B55A

P1476

Q38222585-F7568F63-E64B-46CF-A2EA-86ECDD1ED67D

P2093

Q38222585-37CCE10C-80DF-4F9E-938B-94A658EE14C8

Q38222585-3BC97A0C-4D10-4672-A493-2CB90E68565C

Q38222585-4C7C9FDF-0052-4A30-825B-671C8D7D98CA

Q38222585-66609EB7-C887-4425-84C2-94F0663AF672

Q38222585-87A54180-E1D0-4F1D-B4C2-1920261CD101

Q38222585-9EC4C4C5-EAFB-4031-9749-EF9B9BC8D228

Q38222585-BAD1EB85-788C-4D50-8C85-543169D81DBC

P2860

Q38222585-016B6173-7564-484F-9B3E-A33554AAE06E

Q38222585-040C8516-CB90-441C-A75D-7E61CD52C19A

Q38222585-052A5B2D-8306-4ADC-836D-531330D9C7D5

Q38222585-0B023F91-4B4D-441A-90B7-B6EBD79F7054

Q38222585-0EB06330-C524-4AAC-9025-D11E1602B83E

Q38222585-18BA1FBF-1D77-4F7A-AC2F-5AECB396EFC2

Q38222585-1DD05EC6-5962-4678-B406-32470D425CA3

Q38222585-1EFDD32A-A868-48EE-97A0-0EA90D7C26B9

Q38222585-243F163C-4BC1-4D28-9626-38F266F5DB4E

Q38222585-28768CBE-7505-4429-8D07-10794E5F17E3

P304

Q38222585-5785D916-2A1F-4BBE-B9A8-4C98C68B476F

P31

Q38222585-CFC7420A-1B2B-424D-B954-B40B7CD8567B

P356

Q38222585-6D682340-8AFA-43B1-AAE3-9414C06C8D75

P433

Q38222585-252E8517-6426-4BD8-A21D-9E08FE185693

P478

Q38222585-94A25A63-5F94-442A-A47C-A682D24C5021

P50

Q38222585-0B5BA5F7-35AB-454F-AE10-4B959CFD84C1

Q38222585-2400C013-D6D7-45EE-9BB0-777D7B6F18CA

P577

Q38222585-6D4917FA-4950-4320-B470-99DC28E3D914

P5875

Q38222585-0F9FD720-6644-4DFB-824E-A1D11BE93528

P698

Q38222585-B87AAB66-D9CB-408A-B2D3-C1514B8D9E1F

P356

17474124.2014.922870

P1433

Expert Review of Gastroenterology & Hepatology

P1476

The role of targeted therapy for gastrointestinal tumors

@en

P2093

Antonio Russo

http://www.w3.org/2001/XMLSchema#string

Eugenio Fiorentino

http://www.w3.org/2001/XMLSchema#string

Francesco Passiglia

http://www.w3.org/2001/XMLSchema#string

Ghada Marogy

http://www.w3.org/2001/XMLSchema#string

Giovanni Sortino

http://www.w3.org/2001/XMLSchema#string

Giuseppe Bronte

http://www.w3.org/2001/XMLSchema#string

Konstantinos Papadimitriou

http://www.w3.org/2001/XMLSchema#string

P2860

Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation

Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1

A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular development

Phase II study evaluating 2 dosing schedules of oral foretinib (GSK1363089), cMET/VEGFR2 inhibitor, in patients with metastatic gastric cancer

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

Sorafenib in advanced hepatocellular carcinoma

Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer

Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer

Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium

P304

875-885

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/17474124.2014.922870

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Christian Rolfo

P577

2014-06-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263355733

http://www.w3.org/2001/XMLSchema#string

P698

24957206

http://www.w3.org/2001/XMLSchema#string